inclusion criteria: * positive diagnostic rt-qpcr or antigen test for sars-cov-2 * symptomatic patients with up to 8 days from the onset of symptoms, and asymptomatic cases with up to 5 days of positive test for sars-cov-2. * patients who agree to participate in the study by signing the informed consent.

inclusion criteria: * positive diagnostic rt-qpcr or antigen test for sars-cov-2 * symptomatic patients with up to 8 days from the onset of symptoms, and asymptomatic cases with up to 5 days of positive test for sars-cov-2. * patients who agree to participate in the study by signing the informed consent.

inclusion criteria: - positive diagnostic rt-qpcr or antigen test for sars-cov-2 - symptomatic patients with up to 8 days from the onset of symptoms, and asymptomatic cases with up to 5 days of positive test for sars-cov-2. - patients who agree to participate in the study by signing the informed consent.

inclusion criteria: - positive diagnostic rt-qpcr or antigen test for sars-cov-2 - symptomatic patients with up to 8 days from the onset of symptoms, and asymptomatic cases with up to 5 days of positive test for sars-cov-2. - patients who agree to participate in the study by signing the informed consent.